Disclosed herein are methods for identifying a specific type of a mammalian cell in a sample. The methods can comprise diagnosing a predisposition to a disease. Kits and certain markers in regions of accessible chromatin in the genome are also disclosed herein.

Disclosed herein are methods for identifying a specific type of a mammalian cell in a sample. The methods can comprise diagnosing a predisposition to a disease. Kits and certain markers in regions of accessible chromatin in the genome are also disclosed herein.

The self-contained kit comprises methods for receiving and preparing the biological samples for the nucleic acid amplification and sensing the presence of the target assay. The kit consists of a self-heating pack to provide the heat for nucleic acid sample preparation and amplification processes. The change of the amplification is indicated through colorimetric or turbidity sensing and detected through a mobile phone camera and associated mobile application for photographic scanning of physical or chemical differences of the samples to produce the test results.

The self-contained kit comprises methods for receiving and preparing the biological samples for the nucleic acid amplification and sensing the presence of the target assay. The kit consists of a self-heating pack to provide the heat for nucleic acid sample preparation and amplification processes. The change of the amplification is indicated through colorimetric or turbidity sensing and detected through a mobile phone camera and associated mobile application for photographic scanning of physical or chemical differences of the samples to produce the test results.

Performing sample quantitation and sample amplification may be performed in a sample cartridge or sample cartridges. Sample quantitation using qPCR may be performed during STR PCR on the sample. Samples need not be normalized prior to performing STR PCR. In certain embodiments, qPCR and STR PCR are performed on the same cartridge, optionally at the same time (or in real-time, or overlapping in time) and optionally using some or all of the same PCR apparatus. In other embodiments, qPCR and STR PCR are performed on different cartridges. Quantitation of the STR PCR sample may be performed without substantially delaying the STR PCR process.

Performing sample quantitation and sample amplification may be performed in a sample cartridge or sample cartridges. Sample quantitation using qPCR may be performed during STR PCR on the sample. Samples need not be normalized prior to performing STR PCR. In certain embodiments, qPCR and STR PCR are performed on the same cartridge, optionally at the same time (or in real-time, or overlapping in time) and optionally using some or all of the same PCR apparatus. In other embodiments, qPCR and STR PCR are performed on different cartridges. Quantitation of the STR PCR sample may be performed without substantially delaying the STR PCR process.

The present invention relates to a set of references nucleic acids for use in a method of detecting methylated CpG-containing nucleic acids by nucleic acid amplification and preferably melting curve analysis of amplification products.

The disclosure provides compositions and methods for the quantification of a target nucleic acid sequence or sequences in a sample using next generation sequencing. The methods of the disclosure can be used to determine titer of one or more target organisms in a sample.

The disclosure provides compositions and methods for the quantification of a target nucleic acid sequence or sequences in a sample using next generation sequencing. The methods of the disclosure can be used to determine titer of one or more target organisms in a sample.

Size-band analysis is used to determine whether a chromosomal region exhibits a copy number aberration or an epigenetic alteration. Multiple size ranges may be analyzed instead of focusing on specific sizes. By using multiple size ranges instead of specific sizes, methods may analyze more sequence reads and may be able to determine whether a chromosomal region exhibits a copy number aberration even when clinically-relevant DNA may be a low fraction of the biological sample. Using multiple ranges may allow for the use of all sequence reads from a genomic region, rather than a selected subset of reads in the genomic region. The accuracy of analysis may be increased with higher sensitivity at similar or higher specificity. Analysis may include fewer sequencing reads to achieve the same accuracy, resulting in a more efficient process.